Mathieu P. Seyfrid
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target.
Journal: Science translational medicine
Published: May 13, 2026
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.
Journal: Journal for immunotherapy of cancer
Published: October 25, 2021
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.
Journal: Cell stem cell
Published: March 28, 2019
In Vitro Self-Renewal Assays for Brain Tumor Stem Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 17, 2018
Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
Journal: Journal of neuro-oncology
Published: October 09, 2018
Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment.
Journal: Nature communications
Published: August 10, 2018
Reactive oxygen species contribute toward Smac mimetic/temozolomide-induced cell death in glioblastoma cells.
Journal: Anti-cancer drugs
Published: September 27, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026